$8.16
0.010000.12%
At close: -
$8.02
-0.14-1.72%
After Hours: Mar 5, 8:28 AM EDT
Comments
Loading...
MiNK Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:INKT | Benzinga
MiNK Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 18
EPS Estimate
$-0.050
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of MiNK Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
MiNK Therapeutics (INKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.05 | $-0.08 | 37.5 % |
| Q2 | 2024-08-13 | $-0.07 | $-0.10 | 30.0 % |
| Q1 | 2024-05-14 | $-0.11 | $-0.15 | 26.7 % |
| Q4 | 2024-03-21 | $-0.16 | $-0.15 | -6.67 % |
MiNK Therapeutics (INKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?
MiNK Therapeutics (INKT) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for MiNK Therapeutics (NASDAQ:INKT)?
The Actual EPS was $-0.05, which beat the estimate of $-0.08.
What were MiNK Therapeutics’s (NASDAQ:INKT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.